NYMOX PHARMACEUTICAL CORP Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NYMOX PHARMACEUTICAL CORP for November 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 30 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.81 | 7,000 | 12,660 | 3,265,913 | 3.3 M to 3.3 M (+0.21 %) |
Nov 28 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.71 | 8,000 | 13,679 | 3,258,913 | 3.3 M to 3.3 M (+0.25 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.78 | 6,000 | 10,706 | 3,250,913 | 3.2 M to 3.3 M (+0.18 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.74 | 9,000 | 15,675 | 3,244,913 | 3.2 M to 3.2 M (+0.28 %) |
Nov 21 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.93 | 6,000 | 11,580 | 3,235,913 | 3.2 M to 3.2 M (+0.19 %) |
Nov 15 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.00 | 7,000 | 13,994 | 3,229,913 | 3.2 M to 3.2 M (+0.22 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.14 | 700 | 1,495 | 3,222,913 | 3.2 M to 3.2 M (+0.02 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.12 | 6,300 | 13,374 | 3,222,213 | 3.2 M to 3.2 M (+0.20 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.06 | 5,573 | 11,479 | 3,215,913 | 3.2 M to 3.2 M (+0.17 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.06 | 100 | 206 | 3,210,340 | 3.2 M to 3.2 M (0.00 %) |
Nov 13 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.05 | 327 | 670 | 3,210,240 | 3.2 M to 3.2 M (+0.01 %) |
Nov 09 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 2.04 | 363 | 740 | 3,209,913 | 3.2 M to 3.2 M (+0.01 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Averback Paul | CEO | Sell | S | 1.75 | 100,000 | 175,000 | 23,331,448 | 23.4 M to 23.3 M (-0.43 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Averback Paul | CEO | Sell | S | 2.50 | 1,687,600 | 4,219,000 | 21,643,948 | 23.3 M to 21.6 M (-7.23 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | LANHAM RANDALL J | General Counsel | Buy | P | 1.72 | 2,900 | 4,988 | 152,900 | 150 K to 152.9 K (+1.93 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.98 | 1,050 | 2,079 | 3,209,550 | 3.2 M to 3.2 M (+0.03 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.98 | 4,150 | 8,217 | 3,208,500 | 3.2 M to 3.2 M (+0.13 %) |
Nov 06 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.97 | 1,800 | 3,546 | 3,204,350 | 3.2 M to 3.2 M (+0.06 %) |
Nov 02 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.90 | 6,000 | 11,400 | 3,202,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 02 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.90 | 6,000 | 11,400 | 3,202,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.79 | 6,000 | 10,733 | 3,196,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.79 | 6,000 | 10,766 | 3,190,550 | 3.2 M to 3.2 M (+0.19 %) |
Nov 01 2018 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 1.78 | 6,000 | 10,665 | 3,184,550 | 3.2 M to 3.2 M (+0.19 %) |